BEN2293

· BenevolentAI Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BEN2293, covering 2023-06-18 to 2023-06-18. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis [Phase 1, Phase 2]